• 1
    Vierling JM. Primary biliary cirrhosis. In: ZakimD, BoyerTD, eds. Hepatology Ed 2. Philadelphia: Saunders, 1990: 11581205.
  • 2
    Christensen E, Crowe J, Doniach D, Popper H, Ranek L, Rodes J, Tygstrup N, et al. Clinical pattern and course of disease in primary biliary cirrhosis based on an analysis of 236 patients. Gastroenterology 1980; 78: 236246.
  • 3
    Christensen E, Neuberger J, Crowe J, Altman DG, Popper H, Portmann B, Doniach D, et al. Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Gastroenterology 1985; 89: 10841091.
  • 4
    Roll J, Boyer JL, Barry D, Klatskin G. The prognostic importance of clinical and histological features in asymptomatic and symptomatic primary biliary cirrhosis. N Engl J Med 1983; 308: 17.
  • 5
    Dickson ER, Grambsch PM, Fleming TR, Fisher LD, Langworthy A. Prognosis in primary biliary cirrhosis: a model for decision making. Hepatology 1989; 10: 17.
  • 6
    Epstein O, Jain S, Lee RG, Cook DG, Boss AM, Scheuer PJ, Sherlock S. D-penicillamine treatment improves survival in primary biliary cirrhosis. Lancet 1981; 1: 12751277.
  • 7
    Matloff DS, Alpert E, Resnick RH, Kaplan MM. A prospective trial of D-penicillamine in primary biliary cirrhosis. N Engl J Med 1982; 306: 319326.
  • 8
    Taal BG, Schalm SW, Ten Kate FWJ, Van Berge Henegouwen GP, Brandt K-H. Low therapeutic value of D-penicillamine in a short term prospective trial in primary biliary cirrhosis. Liver 1983; 3: 345352.
  • 9
    Neuberger J, Christensen E, Portmann B, Caballeria J, Rodes J, Ranek L, Tygstrup N, et al. Double blind controlled trial of D-penicillamine in patients with primary biliary cirrhosis. Gut 1985; 26: 114119.
  • 10
    Bodenheimer HC Jr, Schaffner F, Sternlieb I, Klion FM, Vernace S, Pezzullo J. A prospective clinical trial of D-penicillamine in the treatment of primary biliary cirrhosis. Hepatology 1985; 5: 11391142.
  • 11
    Dickson ER, Fleming TR, Weisner RH, Baldus WP, Fleming CR, Ludwig J, McCall JT. Trial of penicillamine in advanced primary biliary cirrhosis. N Engl J Med 1985; 312: 10111015.
  • 12
    Heathcote J, Ross A, Sherlock S. A prospective trial of azathioprine in primary biliary cirrhosis. Gastroenterology 1976; 70: 656660.
  • 13
    Crowe J, Christensen E, Smith M, Cochrane M, Ranek L, Watkinson G, Doniach D, et al. Azathioprine in primary biliary cirrhosis: a preliminary report of an international trial. Gastroenterology 1980; 78: 10051010.
  • 14
    Hoofnagle J, Davis GL, Schafer DF, Peters M, Avigan MI, Pappas SC, Hanson RG, et al. Randomized trial of chlorambucil for primary biliary cirrhosis. Gastroenterology 1986; 91: 13271334.
  • 15
    Wiesner RH, Ludwig J, Lindor KD, Jorgensen RA, Baldus WP, Homburger HA, Dickson ER. A controlled trial of cyclosporine in the treatment of primary biliary cirrhosis. N Engl J Med 1990; 322: 14191424.
  • 16
    Kaplan MM, Ailing DW, Zimmerman HJ, Wolfe HJ, Sepersky RA, Hirsch GS, Elta GH, et al. A prospective trial of colchicine for primary biliary cirrhosis. N Engl J Med 1986; 315: 14481454.
  • 17
    Bodenheimer H Jr, Schaffner F, Pezullo J. Evaluation of colchicine therapy in primary biliary cirrhosis. Gastroenterology 1988; 95: 124129.
  • 18
    Poupon RE, Balkau B, Eschwege E, Poupon R, UDCA-PBC Study Group. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. N Engl J Med 1991; 324: 15481554.
  • 19
    Lindor KD, Dickson ER, Baldus WP, Jorgensen RA, Ludwig J, Murtaugh PA, Harrison JM, et al. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. Gastroenterology 1994; 106: 12841290.
  • 20
    Heathcote EJ, Cauch-Dudek K, Walker V, Bailey RJ, Blendis LM, Ghent CN, Minuk GY, et al. The Canadian multicenter double-blind randomized controlled trial of Ursodeoxycholic acid in primary biliary cirrhosis. Hepatology 1994; 19: 11491156.
  • 21
    Kaplan MM, Knox TA. Treatment of primary biliary cirrhosis with low-dose weekly methotrexate. Gastroenterology 1991; 101: 13321338.
  • 22
    Scheuer PJ. Liver biopsy interpretation. Ed 2. Baltimore: Williams & Wilkins, 1973.
  • 23
    Popper H, Schaffner F. Nonsuppurative destructive chronic cholangitis and chronic hepatitis. In: PopperH, SchaffnerF, eds. Progress in liver disease. Vol 3. New York: Grune & Stratton, 1970: 336354.
  • 24
    Ludwig J, Dickson ER, McDonald GSA. Staging of chronic non-suppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch A Pathol Anat Histopathol 1978; 379: 103112.
  • 25
    Bharucha-Reid AT. Elements of the theory of Markov processes and their applications. New York: McGraw-Hill, 1960: Section 2.3.
  • 26
    Andersen PK, Borgan O, Gill RD, Keiding N. Statistical models based on counting process. New York: Springer-Verlag, 1991: 177228.
  • 27
    Mohleh C, Van Loan C. Nineteen dubious ways to compute the exponential of a matrix. Siam Review 1978; 20: 801836.
  • 28
    Efron F. The jackknife, the bootstrap and other resampling plans. SIAM CBMS-NSF Monograph 1982; 38.
  • 29
    Grambsch PM, Dickson ER, Kaplan M, LeSage G, Fleming RP, Langworthy AL. Extramural cross-validation of the Mayo primary biliary cirrhosis survival model establishes its general-izeability. Hepatology 1989; 10: 846850.
  • 30
    Portmann B, Popper H, Neuberger J, Williams R. Sequential and diagnostic features in primary biliary cirrhosis based on serial histologic study in 209 patients. Gastroenterology 1985; 88: 17771790.